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1. Introduction 
Until relatively recently, the only way non-invasively to study brain cell membrane 
phospholipids in humans in vivo has been through the quantification of membrane 
phospholipid metabolism by means of ascertaining the levels of phosphomonoesters and 
phosphodiesters from 31-phosphorus neurospectroscopy scans. However, this only gives an 
indirect measure of the cell membrane phospholipid molecules. Ideally, one would want to 
study the brain cell membrane motion-restricted phospholipids directly, but it has 
previously proved almost impossible to obtain high-resolution magnetic resonance spectra 
of membrane phospholipids in living tissues owing to the large chemical-shift anisotropy of 
the 31-phosphorus confined to what is, in terms of nuclear magnetic resonance, the 
relatively rigid structure of the cell membrane, whether this be the external cell membrane 
or the membrane of an intracellular organelle.  
2. 31-Phosphorus neurospectroscopy  
Since structural imaging depends on the measurement of proton-based resonances, proton 
neurospectroscopy is readily achievable, in terms of hardware requirements, from magnetic 
resonance imaging scanners that are used for structural neuroimaging studies in humans. In 
contrast, the excitation of 31-phosphorus-containing relatively free moieties from the human 
brain and the measurement of the corresponding 31-phosphorus signals from relaxation of 
the 31-phosphorus nuclei require the use of a different coil tuned to the resonance frequency 
corresponding to the latter nuclei. The resonance frequency, ω, depends also on the strength 
of the static magnetic field, B0, and is given by the Lamor equation: 
 ω = γB0 (1) 
where γ refers to the gyromagnetic constant (or ratio) and is the ratio of the nuclear 
magnetic moment to the nuclear spin angular momentum. The gyromagnetic constant has a 
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unique value for each nuclide possessing a nuclear magnetic moment, such as 31-
phosphorus. For example, the value of the gyromagnetic constant for 31-phosphorus is 17.23 
MHz T-1 while for the proton (1-hydrogen) it is 42.58 MHz T-1. Hence, at a value of B0 of 
1.5 T, which is common for many magnetic resonance scanners in clinical use at the time of 
writing, whereas the value of the resonance frequency is 63.87 MHz for protons, it is just 
under 26 MHz for 31-phosphorus. A method our group have used to allow us to carry out 
31-phosphorus neurospectroscopy studies without having to move each subject’s head in 
relation to the magnetic resonance scanner, is to employ a birdcage quadrature head coil 
dual-tuned to proton (64 MHz) and 31-phosphorus (26 MHz); the proton tuned coil is 
required to enable T1-weighted structural scans to be obtained, in order to allow subsequent 
spectral localization (Puri et al., 2008b). 
Conventional 31-phosphorus neurospectroscopy allows us readily to discern seven narrow 
resonances from the adult human brain. In decreasing order of chemical shift, these are 
signals from phosphomonoesters, inorganic phosphate, phosphodiesters, phosphocreatine, 
gamma nucleotide triphosphate, alpha nucleotide triphosphate, and beta nucleotide 
triphosphate. The first and third narrow resonances, corresponding to phosphomonoesters 
and phosphodiesters, respectively, are considered further below. 
2.1 Phosphomonoesters and phosphodiesters 
The 31-phosphorus neurospectroscopy narrow resonances corresponding to 
phosphomonoesters and phosphodiesters are important in respect of membrane phospholipid 
metabolism for the following reasons.  
The phosphomonoesters narrow resonance reflects membrane phospholipid anabolism. This 
is because it contains contributions from freely mobile phosphomonoesters, including 
phosphocholine, phosphoethanolamine, and even small contributions from inositol 
phosphate, glycerophosphate, phosphothreonine, and L-phosphoserine, and also 
contributions from less mobile phosphomonoester-containing molecules, such as certain 
phosphorylated proteins, and from certain proteins that are part of the neuronal 
cytoskeleton (Puri, 2006).  
In contrast, the phosphodiesters narrow resonance reflects membrane phospholipid 
catabolism, since it contains contributions from freely mobile phosphodiesters, including 
glycerophosphocholine and glycerophosphoethanolamine. The phosphodiesters narrow 
resonance also contains contributions from less mobile phosphodiester-containing molecules, 
such as molecules involved in membrane structure (both cell membranes and intracellular 
organelle membranes) (Puri, 2006).  
Traditionally, therefore, the ratio of phosphomonoesters to phosphodiesters has been used 
as an index of membrane phospholipid metabolism. We turn next to a consideration of the 
presence of a broad component in the 31-phosphorus neurospectroscopy spectrum, which 
enables brain cell membrane motion-restricted phospholipids to be assessed more directly 
than a consideration of just phosphomonoesters and phosphodiesters. 
2.2 Broad component 
In explaining the advantages of measuring the broad component in the 31-phosphorus 
neurospectroscopy signal, the reader may be struck by what is in retrospect a rather ironic 
fact that for many years this broad component has been treated as somewhat of a nuisance, 
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with attempts being made to eliminate it altogether, as far as possible, from the final spectral 
analysis (Estilaei et al., 2001). For example, in previous neurospectroscopy research studies, 
our group have often used a fully automated approach to minimize the baseline roll in 
chemical shift imaging using a technique that employed knowledge-based data processing 
in the frequency domain, the broad component being regarded as an artefact that appeared 
as a result of the summation of several sinc functions; using prior knowledge, a mirror 
component corresponding to the ‘artefact’ was created and added to the delayed spectrum 
and this method compensated for noise and zero-order phase error when computing the roll 
artefact (Saeed and Menon, 1993).  
The broad resonance which underlies the 31-phosphorus spectrum from the living 
mammalian brain is composed of signal directly from the cell membrane phospholipids 
(Hamilton et al., 2003a). Thus the quantification of this broad resonance from 31-phosphorus 
neurospectroscopy data provides a more direct measure of brain cell membrane motion-
restricted phospholipids than does the evaluation of the ratio of phosphomonoesters, which 
index phospholipid anabolism, to phosphodiesters, which index phospholipid catabolism. 
The convolution difference resolution enhancement method may be used to obtain the 
broad component integral, from spectra obtained using an image-selected in vivo 
spectroscopy sequence (ISIS) (Estilaei et al., 2001, Roth and Kimber, 1982), whereby the 
broad component is the difference between the measured raw signal intensity, S, and SCD 
given by: 
 SCD = S(1 – fe-πLt) (2) 
where f is the convolution-difference factor, representing the fraction of the broad 
component contributing to the acquired signal at a given echo time (TE), and L is an 
exponential filter; the broad component integral may then found by fitting the broad 
spectrum to multiple Gaussian lines, minimizing residuals, and summating over all 
Gaussian-line integrals. Estilaei and colleagues (2001) obtained transverse relaxation time 
(T2)-magnetization decay curves by plotting the broad component area as a function of TE; 
having found that mono-exponential fitting did not adequately represent T2-magnetization 
decay curves, they instead used the following bi-exponential fit: 
 S(t) = Sl e-A + Ss e-B (3) 
where S(t) is the total magnetization at a given time t, Sl and Ss are the respective 
equilibrium magnetizations for the slow and fast decaying components, A is the quotient of 
the echo time and the spin-spin relaxation time for the long T2 component, T2l , and B is the 
quotient of the echo time and the spin-spin relaxation time for the short T2 component, T2s. 
Using the model of Radda’s group in which T2l is much greater than T2s (Kilby et al., 1990), 
Estilaei and colleagues (2001) showed that the uncertainty in the determination of the long 
T2 could be eliminated, and, with TE much less than T2l, it followed that 
 ln S(TE) = ln (Sl + Ss) – Ss TE/( T2s (Sl + Ss)) (4) 
and, with TE much greater than T2s 
 ln S(TE) ≃ ln Sl – TE/T2l  (5) 
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Linear regression was then used to carry out the corresponding fits.  
Our group have tended to quantify the 31-phosphorus signals using prior knowledge in 
the temporal domain using the AMARES (advanced method for accurate, robust, and 
efficient spectral fitting) algorithm (Vanhamme et al., 1997) included in the Java-based 
MRUI (magnetic resonance user interface) software program, which allows time-domain 
analysis to be easily carried out (Naressi et al., 2001). Truncation of a specific early portion 
of the signal removes the broad component present in the 31-phosphorus spectra and 
allows initial analysis of the narrow components listed above using a priori knowledge in 
the AMARES algorithm (Hamilton et al., 2003a, Hamilton et al., 2003b). The broad hump 
can then be analyzed, using the above time-domain analysis, thereby allowing distinct 
separation of the narrow and broad components. The broad component is modelled as a 
Gaussian function and its area can be compared with the total peak area of the seven 
narrow resonances and then multiplied by 100 to give the percentage broad signal (Puri et 
al., 2008b). 
2.3 Chronic alcohol consumption 
It has been shown that ethanol increases the fluidity of spin-labelled membranes from 
normal mice, while membranes from mice that have been subjected to long-term ethanol 
treatment are relatively resistant to this fluidizing effect and have an altered phospholipid 
composition; this suggests that the membranes themselves had adapted to the alcohol, 
which constitutes a novel form of drug tolerance (Chin and Goldstein, 1977). This finding 
from this landmark 1977 study has been replicated using non- nuclear magnetic resonance 
techniques, including electron spin resonance and fluorescence polarization: chronic alcohol 
exposure in humans increases the rigidity of isolated brain membranes.  
The related hypothesis that subjects who are heavy drinkers have stiffer brain cell 
membranes than have control subjects who are light drinkers, as reflected in a smaller 
broad signal component with a shorter T2 of the broad signal from 31-phosphorus 
neurospectroscopy, was tested by Estilaei and colleagues (2001). They carried out 
localized 31-phosphorus neurospectroscopy at the level of the centrum ovale in 13 male 
alcohol-dependent heavy drinkers of average age 44 years (standard deviation 9 years) 
who had an average lifetime alcohol consumption of 239 (standard deviation 218) drinks 
per month, where one drink was taken to be an alcoholic beverage containing 
approximately 13 g ethanol, and who satisfied the Diagnostic and Statistical Manual of 
Mental Disorders, fourth edition (DSM-IV) criteria for lifetime dependence on alcohol 
(American Psychiatric Association, 1992). Seventeen male non-dependent light drinkers 
whose average lifetime alcohol consumption was 19 drinks (standard deviation 17 drinks) 
per month, and whose average age (37; standard deviation 10) years was similar to that of 
the first group, acted as the control group for this study. The broad component integral 
was found to be 13 per cent lower in the heavy drinkers compared with the light drinkers 
(p = 0.000 5), while no significant differences were found for any of the metabolite 
integrals. No significant main effect of a family history of alcohol use, assessed using a 
standard questionnaire, was found, and there was no significant family history-by-group 
interaction effect on the broad component integral. No significant correlations were found 
between, on the one hand, the broad component signal integral or its relaxation times, 
and, on the other hand, age, years of abuse, average monthly drinking or total lifetime 
consumption in either the heavy drinking group, or the control group or a combination of 
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both groups. A positive family history of alcohol abuse did not predict a smaller broad 
component integral or shorter relaxation times (Estilaei et al., 2001). In both the heavy 
drinkers and the control group, the T2 distribution of the broad component consistently 
showed two resolvable components, with the fast relaxing component having the same T2 
in both groups while the slower relaxing component T2 was 0.6 ms shorter in the heavy 
drinkers (Estilaei et al., 2001).  
The authors concluded that 31-phosphorus neurospectroscopy ‘provides a powerful and 
practical approach for measuring in vivo changes of the amount and fluidity of 
[phospholipids] in white matter regions of the human brain. Specifically, the smaller, broad 
component in [heavy drinkers] compared with [light drinkers] suggests altered white matter 
[phospholipids] associated with long-term chronic alcohol abuse…[and] may provide 
valuable information regarding possible biochemical mechanisms that [underlie] chronic 
alcohol-induced structural changes…’ (Estilaei et al., 2001). 
2.4 Hypoxia resulting from chronic obstructive pulmonary disease 
The maintenance of cerebral metabolic homeostasis is required for the maintenance of 
consciousness and normal brain function, and this may be perturbed by a variety of 
insults, including hypoxia (Hamilton et al., 2003a). Taylor-Robinson’s group at 
Hammersmith Hospital in London, U.K., had previously shown that abnormal cerebral 
bioenergetics can be detected readily using 31-phosphorus neurospectroscopy in a study 
of 10 patients with stable, but severe, chronic obstructive pulmonary disease and hypoxia; 
compared with controls, the patients with chronic obstructive pulmonary disease showed 
increased phosphomonoesters and inorganic phosphate signals but reduced 
phosphodiesters signals, thought to be caused by the utilization of anaerobic metabolism 
by the brains of hypoxic patients with this disease (Mathur et al., 1999). Since neonatal, 
animal and in vitro studies show an association between anaerobic glycolysis with a 
protective intracellular alkalosis, the same group attempted to identify such a 
compensatory intracellular alkalosis in eight hypoxic patients with chronic obstructive 
pulmonary disease, compared with eight age-matched control subjects, using 31-
phosphorus neurospectroscopy (Hamilton et al., 2003a). As part of this study, the broad 
component was also quantified in the subjects. 
Taylor-Robinson’s group reported that the mean intracellular pH in patients with chronic 
obstructive pulmonary disease was similar to that in the control subjects, but decreased in 
the patients by a mean of 0.02 following the administration of supplemental oxygen, there 
being no such change in normal control subjects following oxygen administration. Of 
particular interest was their finding that the broad component increased in all the patients 
with chronic obstructive pulmonary disease following oxygen administration (Hamilton et 
al., 2003a). These findings point to altered phospholipid membrane fluidity in the brain 
being associated with the change in intracellular pH following oxygen administration. The 
change in the broad resonance was strongly and negatively correlated with the change in 
intracellular pH, and indeed in vitro studies have shown that membrane fluidity is sensitive 
to pH with, for example, the fusion process between synaptosomes, freshly isolated from rat 
brain cortex, and large unilamellar phosphatidylserine liposomes being shown to be pH 
dependent (an increase in both kinetics and extent occurring when the pH is lowered by 1.9 
from 7.4) (Almeida et al., 1994).  
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Based on the above findings, including the results relating to the broad component from 31-
phosphorus neurospectroscopy, the authors hypothesized that the transition from 
compensatory respiratory failure in patients with hypoxic chronic obstructive pulmonary 
disease to the clinical picture of confusion, disorientation and coma in patients with chronic 
obstructive pulmonary disease and with severe exacerbations may be associated with the 
failure of ion transport mechanisms, perturbation of membrane fluidity and the 
overwhelming of the compensatory intracellular alkalosis in neuronal and glial cells 
(Hamilton et al., 2003a). 
2.5 Schizophrenia 
A number of lines of evidence from biochemical studies have suggested that membrane 
phospholipid metabolism may be impaired in at least a subgroup of patients suffering 
from schizophrenia (Puri et al., 2008a). First, reduced levels of highly unsaturated (or 
polyunsaturated) fatty acids have been reported in erythrocyte membranes (Yao and 
van Kammen, 1994, Yao et al., 1994a, Yao et al., 1994b, Peet et al., 1995) in patients with 
schizophrenia. Second, increased levels of the phospholipase A2 group of enzymes, 
which catalyze the removal of highly unsaturated (or polyunsaturated) fatty acids such 
as arachidonic acid and docosahexaenoic acid from the Sn2 position of membrane 
phospholipid molecules, have been found in both plasma (Gattaz, 1992, Gattaz et al., 
1990, Gattaz et al., 1987, Tavares et al., 2003) and platelets (Gattaz et al., 1995) of 
patients with schizophrenia. Furthermore, the dermatological response to the niacin 
flush test, which indirectly indexes membrane phospholipid metabolism, has been 
found to be impaired in schizophrenia (Ward et al., 1998), including in its quantitative 
measurement form as the volumetric niacin response (Puri et al., 2002). These 
converging lines of evidence are consistent with the membrane phospholipid 
hypothesis of schizophrenia, associated with the late Professor David F. Horrobin, and 
also with Professor Iain Glen and Professor Krishna Vaddadi, which proposes a change 
in brain membrane phospholipids leading in turn to changes in the functioning of 
membrane-associated proteins and of cell signalling systems in schizophrenia 
(Horrobin, 1996, Horrobin, 1998, Horrobin et al., 1994). 
Clearly, the above biochemical studies have not directly measured membrane 
phospholipids from the brains of patients suffering from schizophrenia. Similarly, as 
mentioned earlier, the quantification of the ratio of phosphomonoesters to phosphodiesters, 
gleaned from narrow resonances obtained from 31-phosphorus neurospectroscopy, also 
only provide an indirect measure of the ratio of brain cell membrane phospholipid 
anabolism to phospholipid catabolism. Therefore, there is a clear role for analyzing the 
broad component from 31-phosphorus neurospectroscopy in schizophrenia. Accordingly, 
our group were the first to do so. 
In our initial study, we carried out the first analysis of the broad component resonance 
from the brain in forensic patients severely affected with schizophrenia and a comparison 
group of age- and gender-matched healthy normal control subjects, to assess directly 
whether, as expected under the membrane phospholipid hypothesis of schizophrenia, 
there was a change in cell membrane phospholipids in people suffering from 
schizophrenia who have a forensic history such as having perpetrated an act of serious 
violence while psychotic (Puri et al., 2008b). Fifteen male inpatients in a medium secure 
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unit with a diagnosis of schizophrenia according to DSM-IV (American Psychiatric 
Association, 1992), and 12 male healthy control subjects underwent 31-phosphorus 
neurospectroscopy. Expert psychiatric opinion, accepted in court, was that all the patients 
had violently offended directly as a result of schizophrenia prior to admission to the unit, 
these offences consisting of homicide, attempted murder, or wounding with intent to 
cause grievous bodily harm. There was no history of alcohol dependency in these patients 
or in the control subjects. All the patients were suffering from severe positive symptoms 
of schizophrenia, mostly controlled by antipsychotic medication at the time of scanning. 
The average duration of illness since the index offence was 6.8 (standard error 0.4) years. 
Fourteen of the patients were being treated with typical antipsychotic medication, mainly 
in injectable depot form, while the remaining patient was being treated with clozapine. 
Spectra were obtained using an image-selected in vivo spectroscopy sequence with 64 
signal averages localized on a 70 x 70 x 70 cubic millimetre voxel. Owing to the low 
abundance in the brain, and indeed the rest of the body, of 31-phosphorus compared with 
protons, the maximum size voxel was used to collect signal from the brain and thus 
maximize the signal-to-noise ratio. All spectral analyses were carried out by a single 
observer who was blinded to group allocation until after the spectral and statistical 
analyses were completed. It was found that the mean percentage broad component signal 
for the patients did not differ significantly from that for the control subjects and therefore 
it was not possible to reject the null hypothesis that there is no difference in the 
concentration of brain membrane-bound phospholipids in this group of forensic patients 
with schizophrenia compared with controls. 
The above finding from analysis of the broad component in forensic patients with 
schizophrenia was a surprise to our group. An explanation based on the notion that the 
membrane phospholipid hypothesis applies not only to the outer cell membranes but also to 
the phospholipid membranes of intracellular organelles such as the nucleus and 
mitochondrion does not hold since the broad component resonance signal derives from both 
the outer cell membranes and the phospholipid membranes of these organelles (Puri et al., 
2008b).  
We carried out a review of the evidence relating to the membrane phospholipid 
hypothesis of schizophrenia (Puri et al., 2008b). There is strong evidence favouring this 
hypothesis. As alluded to above, much of this evidence is, as might be expected, primarily 
biochemical in nature. Plasma phospholipids that have been studied in schizophrenia 
have tended to show reduced levels of the n-6 (or omega-6) fatty acids linoleic acid and 
arachidonic acid and raised levels of n-3 (or omega-3) fatty acids (Horrobin et al., 1989). 
Interestingly, in a study of plasma phospholipids in patients with schizophrenia, patients 
with affective and paranoid disorders, and normal controls, from Japan, it was found that 
while the patients with schizophrenia had low linoleic acid levels (and a low ratio of 
linoleic acid to its metabolites), and while phospholipid fatty acid levels were in the 
normal range for the patients with paranoid or affective disorders, those patients with 
schizophrenia who showed reduced platelet sensitivity to the aggregation-inhibiting 
effects of prostaglandin E1 had higher levels of oleic acid and lower levels of 
eicosapentaenoic acid (Kaiya et al., 1991). This possibility of a dichotomous nature to the 
fatty acid changes in plasma in schizophrenia also extends to erythrocyte membrane fatty 
acids.  
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Erythrocyte membrane fatty acid changes in schizophrenia have been found more 
consistently than plasma fatty acid changes (Puri et al., 2008b). They tend to point to 
reduced erythrocyte membrane levels of the long-chain polyunsaturated fatty acids 
arachidonic acid and docosahexaenoic acid, in the context of a biphasic distribution with 
one group of schizophrenia patients having essentially normal fatty acid levels, while the 
other has significantly low levels (Glen et al., 1994). It is of particular interest to note that 
when the schizophrenia patients were divided into those with predominantly negative 
symptoms, such as affective flattening, and predominantly positive syndromes, including 
positive symptoms such as auditory hallucinations and thought disorder, the low 
erythrocyte membrane levels of arachidonic acid and docosahexaenoic acid were largely 
confined to patients with a negative syndrome (Horrobin, 2003).  
Clearly it was the case that the schizophrenia patients in the above broad component 31-
phosphorus neurospectroscopy study would all fit into the category of a positive syndrome, 
given their history of seriously and violently offending while psychotic (Puri et al., 2008b) . 
Therefore, this may provide a possible explanation as to why the results of this study did 
not harmonize with the neurospectroscopy changes expected under the membrane 
phospholipid hypothesis of Horrobin, Glen and Vaddadi. It was therefore decided to carry 
to a further study of the broad component from 31-phosphorus neurospectroscopy scanning 
of patients with schizophrenia, but this time of a sample taken from patients who had not 
seriously or violently offended as a result of their illness and who suffered from 
predominantly negative symptoms. 
For our new 31-phosphorus neurospectroscopy investigation, our group studied 16 
psychiatric outpatients who had a diagnosis of schizophrenia according to DSM-IV 
(American Psychiatric Association, 1992), who had no history of dependency on 
psychoactive substances, and the same number of normal healthy controls, who had no 
previous history of psychiatric or neurological disorders. The two groups were matched 
with respect to age and gender. The patients suffered from mild to moderate negative 
symptoms of schizophrenia and had no history of having committed any violent or other 
offences as a result of their schizophrenic illness. The 31-phosphorus neurospectroscopy 
protocol was as mentioned above for the forensic schizophrenia study, with spectra being 
obtained from an image selected in vivo spectroscopy sequence with 64 signal averages 
localized on a 70 x 70 x 70 cubic millimetre voxel, with the signal-to-noise ratio again being 
improved by using this large voxel size (Puri et al., 2008a).  
The broad component from each subject was quantified by an observer who at the time of 
this analysis was blinded to group status. Just as in our previous study mentioned above, 
analysis of these broad resonances in this new study showed no significant difference in the 
broad component between the group of patients with schizophrenia and the normal control 
group.  
We considered that an explanation of these negative results might lie in the possibility 
that the membrane phospholipid hypothesis of schizophrenia could possibly be construed 
as predicting a change only in phospholipid metabolism in the cell membranes of the 
brain, rather than a change in the membrane-bound phospholipids themselves. To test 
this possibility, a further blinded analysis was carried out of the percentage 
phosphomonoesters (indexing phospholipid anabolism) and phosphodiesters (indexing 
phospholipid catabolism) levels in both groups. The mean (standard error) percentage 
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phosphomonoesters level for the patients with schizophrenia was 11.4 (0.3) and did not 
differ significantly from that for the normal control subjects of 10.9 (0.5). Similarly, the 
mean (standard error) percentage phosphodiesters level for the schizophrenia patients 
was 44.4 (0.5), which did not differ significantly from that for the normal control subjects 
of 44.6 (0.9) (Puri et al., 2008a). In terms of ratios, the mean ratio of phosphomonoesters to 
phosphodiesters was 0.26 (standard error 0.01) in the case of the patients with 
schizophrenia and 0.25 (standard error 0.01) for the healthy controls (Puri et al., 2008a), 
and again these did not differ significantly. Therefore, on the basis of this second study, it 
was not possible to reject the null hypothesis that there was no difference in phospholipid 
metabolism in the brain in the schizophrenia patients compared with the age- and gender-
matched control subjects. 
Our two sets of ‘negative’ results in schizophrenia do not, of course, negate the value of 
quantifying the broad component gleaned from 31-phosphorus neurospectroscopy studies. 
Rather, they must give us cause to examine again the membrane phospholipid hypothesis of 
schizophrenia. 
3. Conclusion  
The above studies of chronic alcohol dependence, chronic obstructive pulmonary disease, 
forensic inpatients with schizophrenia who have seriously and violently offended while 
psychotic, and of outpatients with schizophrenia who are suffering from predominantly 
mild to moderate negative symptoms of schizophrenia, have demonstrated the feasibility of 
analyzing the broad component from 31-phosphorus neurospectroscopy studies in a wide 
range of patient groups. We have also shown the advantages over analysis of narrow 
resonances corresponding to levels of phosphomonoesters (indexing phospholipid 
anabolism) and phosphodiesters (indexing phospholipid catabolism) of the analysis of this 
broad component in order to quantify the level of motion-restricted membrane 
phospholipids in the brains of the individuals being studied. 
The failure of our broad component analyses to yield results which harmonize with the rich 
biochemical literature that is consistent with the membrane phospholipid hypothesis of 
schizophrenia does insert a possible note of caution, however. It should be noted that, given 
the low signal-to-noise in 31-phosphorus magnetic resonance spectroscopy, the areas of the 
peaks obtained are inherently variable (Puri et al., 2008a). This is particularly true of the 
underlying broad component, which has a coefficient of variation double that of the other 
peaks visible in the spectrum (Hamilton et al., 2003b). One should take into account the 
possibility that this variability may be masking any changes in the broad component, 
leading to a reduction in the ability to monitor membrane phospholipids. 
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